David Miles

8.4k citations
142 papers · 5.8k indexed · 2 hit papers · h-index 35

Impact in

  • Finance top 0.5%
    • Banking stability, regulation, efficiency
  • Oncology top 1%
    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research
    • Colorectal Cancer Treatments and Studies

Papers in

David Miles

136 papers receiving 5.4k citations

Hit Papers

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook 2020 · 780 citations
7802002202620102018250500750

Peers

David Miles
Comparison fields: 5 of 190
  • Finance 1.1k
  • Oncology 2.6k
  • Cancer Research 1.1k
  • General Economics, Econometrics and Finance 598
  • Accounting 677
Replace Robert W. Jackman with:
Robert W. Jackman United States
Lu Zhang China
Kenneth J. Kopecky United States
Ashraf Khan United States
Charles Brown United States
Thomas J. George United States
Gary J. Miller United States
Göran Roos Sweden
Eugene Kandel United States
Robert E. Scott United States
David Miles relative to Robert W. Jackman United States Robert W. Jackman's profile →
Citations per field
00.5×5.9×
Robert W. Jackman · 1×
Citations per year

Countries citing papers authored by David Miles

Since Specialization
Citations

This map shows the geographic impact of David Miles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Miles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Miles more than expected).

Fields of papers citing papers by David Miles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Miles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Miles. The network helps show where David Miles may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David Miles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Miles Line = papers co-authored together David Miles links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20179
2 201212
3 201242
4 201152
5
Financial Innovation and European Housing and Mortgage Markets
20083
6 20074
7 200518
8 20039
9 200382
10
Optimal Social Security Design
20023
11
Survival benefit with Xeloda (capecitabine)/docetaxel vs docetaxel: analysis of post-study therapy.
200112
12 2001258
13
Funded and Unfunded Pension Schemes: Risk, Return and Welfare
20002
14
Housing in the South East of England
20002
15 19999
16 1999153
17
The Reform of Pension Systems: Winners and Losers Across Generations
19984
18
Modelling the Impact of Demographic Change Upon the Economy
19977
19
Commercial dispute resolution : an ADR practice guide
19958
20
War and Society
197661

About David Miles

David Miles is a scholar working on Accounting, Finance, Oncology, Cancer Research and Economics and Econometrics, having authored 142 papers that have together received 5.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (46 papers), Financial Literacy, Pension, Retirement Analysis (25 papers), Breast Cancer Treatment Studies (24 papers), HER2/EGFR in Cancer Research (21 papers), Advanced Breast Cancer Therapies (20 papers), Housing Market and Economics (18 papers), Colorectal Cancer Treatments and Studies (16 papers) and Global Health Care Issues (12 papers). The work is most often cited by research in Finance (1.1k citations), Oncology (2.6k citations), Cancer Research (1.1k citations), General Economics, Econometrics and Finance (598 citations) and Accounting (677 citations). David Miles has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Herbert I. Hurwitz, Alan B. Sandler, Regula Deurloo, Robert L. Coleman, Olivier Chinot, Josep Garcia, Joyce O’Shaughnessy, L. Mauriac, Vladimir Moiseyenko and Stephen E. Jones. Their work appears in journals such as The Economic Journal, Journal of Clinical Oncology, Cancer Research, European Journal of Cancer and International Journal of Clinical Practice.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026